We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rii | LSE:RIN | London | Ordinary Share | GB0007383234 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | - | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
27/1/2005 10:53 | Not much in the way of posts... "400 mln shares at 0.75 pence per share to finance the new business. The placing, which will raise 2.695 mln stg, will provide additional working capital for the next 12 months." IMO, much better to have raised more money without such a volume of shares. What happens in 12 months? Further dilutions? More money to burn? Seen so many of this Bio companies raising money and coming back the markets for more...Why pay 4-5p when 0.75p is the sp? come on someone tell me whats so good about this deal? | daz2004 | |
27/1/2005 10:44 | hi - i've been looking at this one this morning, following the piece in the Daily Mail. I don't know if anyone can help answer a question about tonabersat - I notice that the patent is held by SB, and that a milestone payment of £5m would be due on initiation of Phase III trials. As I understand it, Biopartners have not yet started Phase II trials with this compound, so there is a long way to go before that milestone payment would be due -- Is this correct? The other thing I notice is that Paul Sharpe is a medical doctor, not a PhD. So I'm not too convinced about his scientific credentials - he would have no expertise, that I can tell, in biopharmaceutical research. There are a few published articles I could find about tonabersat - which might be used to support 'proof of concept', but there doesn't seem to be any overwhelming evidence, at this point, that the compound is likely to be effective in treatment. Any views from anyone who's been following this for longer than me (i.e, three hours). cheers, growbag | growbag | |
27/1/2005 10:18 | cimbom - its the number of shares, 400 million, and only a few million raised. | daz2004 | |
27/1/2005 10:13 | Well what a surprise.I didn't even know these had come back today.Things are looking good.This still has a long way to go. | cimbom | |
27/1/2005 10:09 | Thanks cityfarmer | lecks | |
27/1/2005 10:04 | Lecks, Coz we all new it was going to happen so no great surprise! The papers will get hold of it tomorrow and over the weekend but these new shares will take a bit of digesting. Should find a level then steady progress from there.... | cityfarmer | |
27/1/2005 09:55 | Cheers Cityfarmer, Like your style, but why is this not reflected in the share price? "I can stiil buy today, though, for close to what they were prior to suspension | lecks | |
27/1/2005 09:44 | Lecks, In a nut shell, you have gone from a company that does sweet FA to one of the most exciting on the stock market! | cityfarmer | |
27/1/2005 09:33 | Might buy a few from City Equities at 1p | the knowing | |
27/1/2005 09:32 | can someone tell me in plain english what's so good about this deal for existing RII shareholders | lecks | |
27/1/2005 09:02 | I have just a few of these prior to new listing...was going to add but this bit doesn't inspire me, tell me I'm wrong, but 400million shares and possibly further dilution doesn't look that fantastic in the medium term... "the Company may need to raise further funds after this period in order to implement fully its business plan and, in due course, to satisfy the milestone payments under the licences. Milestone payments may be funded wholly or in part by partnering arrangements or by other external funding methods including the issue of further Ordinary Shares." | daz2004 | |
27/1/2005 08:45 | Good rise today but I think the new name, Minster Pharmaceuticals, is a bit uninspired | sandbank | |
27/1/2005 08:42 | Taken from Geoff Foster's column in the Daily Mail today 27th January 2005.... DEALINGS in Aim-quoted RII resume today at 3⅞p following the reverse takeover of BioPartners. Buyers should be all over it like a rash because Bio Partners has rights to two potential blockbuster drugs that were spun out of Glaxo at the time of its merger with SmithKlineBeecham. Tonabasat, a migraine drug, is expected to enter Phase III shortly. The other is a treatment for schizophrenia due to finish Phase II trials this year. | ander | |
27/1/2005 08:01 | very quiet here - we should be having a lively discussion! | lecks | |
27/1/2005 07:17 | 400m shares! | davidcod | |
27/1/2005 07:16 | RII Plc ("RII" or "the Company") Proposed Acquisition of BioPartners Limited Placing of 400,000,000 Ordinary Shares at 0.75p per share Approval of Rule 9 Waiver Admission of the enlarged Share Capital to trading on AIM Change of name to Minster Pharmaceuticals plc and Notice of Extraordinary General Meeting Application has been made to the London Stock Exchange for all the Ordinary Shares in issue following approval of the Proposals by the RII Shareholders and the waiver by the Panel on Takeovers and Mergers of any requirement for a general offer to be made under Rule 9 of the City Code on Takeover and Mergers to be admitted to trading on AIM. It is expected that Admission of the Ordinary Shares will become effective and dealings will commence in such shares on 25 February 2005. CREST accounts of placees, whose shares are held via that system, will be credited on Admission and certificates in respect of other placees will be sent to them within 21 days thereof. | jackyboy | |
26/1/2005 14:00 | Rice and Onions = Bio Partners.. yum yum! | cityfarmer | |
26/1/2005 13:58 | Cliffproud Thanks, I hear you - just not very familiar with what normally happens / or likely scenario in a reverse takeover / how it is likely to affect existing rii shareholders etc.. etc..etc.. If I did, it would put me in a more comfortable position re what to do when it does happen - "the suspense is killing me!" Hi Harry, Hows it goin! Bit of a contradiction in this one; "taking the longer view this share will very soon become the best performing growth stock to invest into imho" | lecks | |
26/1/2005 13:24 | LECKS Just don't rush to sell. Basilrathbone Forget Rosetta, my monies on BP. | cliffproud | |
26/1/2005 11:11 | taking the longer view this share will very soon become the best performing growth stock to invest into imho | harry punter | |
25/1/2005 22:34 | We could all be very happy people. | cimbom | |
25/1/2005 22:33 | If they do come out of suspension tomorrow, what is likely to happen | lecks | |
25/1/2005 12:08 | Could it be Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co? That company uses a web address of www.rii.com . It was brought by Merck in 2001, perhaps they now want to spin in out on AIM? :-) | basilrathbone | |
24/1/2005 19:54 | There's the rub, we don't yet know the terms of the deal to reverse the business into RII, but it's going to be fun. | cliffproud | |
24/1/2005 16:03 | Gets more intriguing by the day - so what is the deal with Bio Partners | lecks |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions